You are here

Member Profile

Membership type: full

Nadia Hamdy

Country of origin: Egypt Currently in: Egypt, Cairo General field of specialization: Biological Systems and Organisms
Academic Background


2007 Doctorate Biological Systems and Organisms
Research and Profession

Current Research Activities

Biological Systems and Organisms

Biomarkers; Molecular and Immunological, Oncology; Breast and Liver, Biological, Molecular and Immunological Biomarkers and their relationship to cancer. Progress in Immunology and cancer. Genetic studies; genomics and epigenetics, of several diseases, including cancer; the relationship of genes to cause cancer or treatment success/failure or resistance,.. Obesity and Insulin resistance related diseases, Liver diseases, Regenerative Medicine, Drug repurposing.

Publications resulting from Research: 

[1] Nadia M Hamdy, Reham A El-Shemy 2020, Molecular Profiling of Breast Cancer
Susceptibility of Obese or Insulin-Resistant and Pre-Diabetic Patients Using ITLN1 and CD295 SNPs,
medRxiv 2020.01.08.20016980; doi:

[2] El-Mesallamy HO, El Magdoub HM, Chapman JM, Hamdy NM, Schaalan MF, Hammad LN, Berger SH, Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach. PLoS One. 2018 Mar 14;13(3):e0193810. doi: 10.1371/journal.pone.0193810.

[3] Khella MS, Hamdy NM, Amin AI, El-Mesallamy HO, The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: a
case- control study. BMC Medical Genetics. 2017;18:101. doi:10.1186/s12881-017-0461-0.

[4] Eman F. Sanad, Nadia M. Hamdy, Adel K. El-Etriby, Hala O. El-Mesallamy, Peripheral leucocytes and tissue gene expression of granzyme B/perforin system and serpinB9: Impact on inflammation and insulin resistance in coronary atherosclerosis. Diabetes research and clinical practice; 2017; 131:132-141. doi: 10.1016/j.diabres.2017.07.013.

[5] Youssef SS, Hamdy NM, Suppressor of Cytokine Signaling 1 (rs243327), Toll-Like Receptor-9 (rs352140) and Retinoic Acid Inducible Gene-I (rs669260) SNPs Haplotype Novel Association in Egyptian Fibrotic/Cirrhotic Patients from HCV Genotype 4. Archives of virology; 2017 accepted 5 July. DOI: 10.1007/s00705-017-3498-7

[6] Mostafa AM, Hamdy NM, Abdel-Rahman SZ, El-Mesallamy HO, Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytes. IUBMB Life. 2016 Jul;68(7):535-43.

[7] Amany M. Kamal, Nadia H. El-Hefny, Hany M. Hegab, Hala O. El-Mesallamy, Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study. Hematology; May 2016; 1-9. DOI: 10.1080/10245332.2016.1173341

[8] Hanan M. Hosni, Nadia M. Hamdy, Nadia L. Al-Ansari and Hala O. El-Mesallamy, Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4. PLOS One; 2016; Apr 21;11(4):e0153895. DOI:10.1371/journal.pone.0153895.
[9] SaraM.Radwan,NadiaM.Hamdy,HanyM.Hegab,HalaO.El-Mesallamy,Beclin-1 and hypoxia-inducible factor-1alpha genes expression: potential biomarkers in acute leukemia patients. Cancer biomarkers, 2016 Mar 18;16(4):619-26. doi: 10.3233/CBM-160603.
[10]Marwa O. El-Derany, Nadia M. Hamdy, Nadia L. Al-Ansari and Hala O. El-Mesallamy, Integrative role of vitamin D related and Interleukin-28B genes polymorphism in predicting treatment outcomes of Chronic Hepatitis C. BMC Gastroenterology (2016) 16:19 DOI 10.1186/s12876-016-0440-5.

Current profession

Current professional activities type: 
Prof. of Biochemistry and Biochemistry Dept. Head, Faculty of Pharmacy, Ain Shams University

Search form